Literature DB >> 33850139

Moss enables high sensitivity single-nucleotide variant calling from multiple bulk DNA tumor samples.

Chuanyi Zhang1, Mohammed El-Kebir2, Idoia Ochoa3,4.   

Abstract

Intra-tumor heterogeneity renders the identification of somatic single-nucleotide variants (SNVs) a challenging problem. In particular, low-frequency SNVs are hard to distinguish from sequencing artifacts. While the increasing availability of multi-sample tumor DNA sequencing data holds the potential for more accurate variant calling, there is a lack of high-sensitivity multi-sample SNV callers that utilize these data. Here we report Moss, a method to identify low-frequency SNVs that recur in multiple sequencing samples from the same tumor. Moss provides any existing single-sample SNV caller the ability to support multiple samples with little additional time overhead. We demonstrate that Moss improves recall while maintaining high precision in a simulated dataset. On multi-sample hepatocellular carcinoma, acute myeloid leukemia and colorectal cancer datasets, Moss identifies new low-frequency variants that meet manual review criteria and are consistent with the tumor's mutational signature profile. In addition, Moss detects the presence of variants in more samples of the same tumor than reported by the single-sample caller. Moss' improved sensitivity in SNV calling will enable more detailed downstream analyses in cancer genomics.

Entities:  

Year:  2021        PMID: 33850139     DOI: 10.1038/s41467-021-22466-9

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  33 in total

1.  Strelka2: fast and accurate calling of germline and somatic variants.

Authors:  Sangtae Kim; Konrad Scheffler; Aaron L Halpern; Mitchell A Bekritsky; Eunho Noh; Morten Källberg; Xiaoyu Chen; Yeonbin Kim; Doruk Beyter; Peter Krusche; Christopher T Saunders
Journal:  Nat Methods       Date:  2018-07-16       Impact factor: 28.547

2.  A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy.

Authors:  Marta Łuksza; Nadeem Riaz; Vladimir Makarov; Vinod P Balachandran; Matthew D Hellmann; Alexander Solovyov; Naiyer A Rizvi; Taha Merghoub; Arnold J Levine; Timothy A Chan; Jedd D Wolchok; Benjamin D Greenbaum
Journal:  Nature       Date:  2017-11-08       Impact factor: 49.962

3.  Inferring the Mutational History of a Tumor Using Multi-state Perfect Phylogeny Mixtures.

Authors:  Mohammed El-Kebir; Gryte Satas; Layla Oesper; Benjamin J Raphael
Journal:  Cell Syst       Date:  2016-07       Impact factor: 10.304

4.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

Review 5.  The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers.

Authors:  Zbyslaw Sondka; Sally Bamford; Charlotte G Cole; Sari A Ward; Ian Dunham; Simon A Forbes
Journal:  Nat Rev Cancer       Date:  2018-11       Impact factor: 60.716

6.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

Authors:  Marco Gerlinger; Andrew J Rowan; Stuart Horswell; James Larkin; David Endesfelder; Eva Gronroos; Pierre Martinez; Nicholas Matthews; Aengus Stewart; Charles Swanton; M Math; Patrick Tarpey; Ignacio Varela; Benjamin Phillimore; Sharmin Begum; Neil Q McDonald; Adam Butler; David Jones; Keiran Raine; Calli Latimer; Claudio R Santos; Mahrokh Nohadani; Aron C Eklund; Bradley Spencer-Dene; Graham Clark; Lisa Pickering; Gordon Stamp; Martin Gore; Zoltan Szallasi; Julian Downward; P Andrew Futreal
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

7.  MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data.

Authors:  Yu Fan; Liu Xi; Daniel S T Hughes; Jianjun Zhang; Jianhua Zhang; P Andrew Futreal; David A Wheeler; Wenyi Wang
Journal:  Genome Biol       Date:  2016-08-24       Impact factor: 13.583

8.  The repertoire of mutational signatures in human cancer.

Authors:  Ludmil B Alexandrov; Jaegil Kim; Gad Getz; Steven G Rozen; Michael R Stratton; Nicholas J Haradhvala; Mi Ni Huang; Alvin Wei Tian Ng; Yang Wu; Arnoud Boot; Kyle R Covington; Dmitry A Gordenin; Erik N Bergstrom; S M Ashiqul Islam; Nuria Lopez-Bigas; Leszek J Klimczak; John R McPherson; Sandro Morganella; Radhakrishnan Sabarinathan; David A Wheeler; Ville Mustonen
Journal:  Nature       Date:  2020-02-05       Impact factor: 49.962

9.  Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications.

Authors:  Andy Rimmer; Hang Phan; Iain Mathieson; Zamin Iqbal; Stephen R F Twigg; Andrew O M Wilkie; Gil McVean; Gerton Lunter
Journal:  Nat Genet       Date:  2014-07-13       Impact factor: 38.330

10.  LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets.

Authors:  Andreas Wilm; Pauline Poh Kim Aw; Denis Bertrand; Grace Hui Ting Yeo; Swee Hoe Ong; Chang Hua Wong; Chiea Chuen Khor; Rosemary Petric; Martin Lloyd Hibberd; Niranjan Nagarajan
Journal:  Nucleic Acids Res       Date:  2012-10-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.